However, studies have revealed that ADT and anti-androgen treatment result in the back-differentiation of some AR-positive PCa cells into PCSCs, which are inherently resistant to AR targeted therapies due to their negative AR characteristics. The gene discussed is AR; the disease is posterior cortical atrophy.